Moteur de recherche d’entreprises européennes
Financement de l’UE (7 203 363 €) : Programme eXponentiel COVID Hor21/10/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Programme eXponentiel COVID
COVID-X will bridge the collaboration divide between eHealth solution providers -with emphasis on lean startups and small and medium-sized enterprises (SMEs)-, and the healthcare professional system to fight COVID-19. The purpose is to boost an end-to-end agile validation programme of cutting-edge technology in three real-world clinical scenarios, located in hotspots of the pandemic: Italy, Spain and Sweden. The project will fast-track value streams between the two poles under consideration: 1) attract, invest and empower a community of European eHealth SMEs –the beneficiaries of an acceleration program, selected by open calls- that will provide market-ready fast, cost-effective and easily deployable sampling, screening, diagnostic and prognostic systems and/or data-driven services and tools, already certified with -or close to receive- the CE marking (type 1 of the call); 2) actively involve some of the most relevant hospitals of Europe that have the resources, critical mass and ambition to scale-up their capabilities in the COVID-19 response; thanks to the support of an innovative data sandbox, released as an in-house asset of COVID-X, to facilitate access easily, uniformly and securely to various health data sources, and providing data services including Artificial Intelligence (AI)-based decision support systems, data security, visual analytics and intuitive dashboards capabilities. The project will invest dedicated efforts to enforce data privacy and security, ethical compliance and user acceptance. Besides a solid consortium to access world class startups/SMEs, deliver highly valuable technological & business services, provide an innovative data Sandbox with AI capabilities for COVID related services and access 3 piloting sites, COVID-X targets to attract +155 applications and select 31 to undertake through the COVID-X Programme, investing a total of €4.0mil in high impact solution providers.
| Australo Interinnov Marketing Lab SL | 124 250 € |
| Bosonit SL | 135 625 € |
| Eight Bells Ltd. | 138 600 € |
| F6S Network Ireland Ltd. | 211 819 € |
| F6S Network Ltd. | 0,00 € |
| Fundacion para La Investigacion Biomedica del Hospital Universitario Clinico San Carlos | 0,00 € |
| Humanitas Mirasole S.p.A. | 548 625 € |
| Karolinska Institutet | 414 250 € |
| Netcompany SA | 492 975 € |
| Servicio Madrileno de Salud | 319 750 € |
| Universidad Politecnica de Madrid | 4 498 375 € |
| VSI Civitta Foundation | 319 094 € |
https://cordis.europa.eu/project/id/101016065
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Australo Interinnov Marketing Lab SL - Financement de l’UE (7 203 363 €) : Programme eXponentiel COVID"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
